7 Best Peptides for Inflammaging
Inflammaging, the chronic low-grade inflammation that accumulates silently with age, is considered a central driver of cardiovascular disease, neurodegeneration, metabolic decline, and most other serious age-related conditions. Seven peptides are actively used and discussed for addressing it in 2026, ranging from SS-31, which has completed Phase II clinical trials, to mitochondria-derived MOTS-c, whose evidence is preclinical but whose biological rationale draws growing research interest. The compounds below are ordered by how prominently each appears in research and documented real-world use, not as a recommendation of one over another. Because inflammaging has multiple biological drivers, the peptide that fits a given person depends on which driver is most prominent, and that decision belongs in a personalized plan.
